Liquidity ratios measure the company ability to meet its short-term obligations.
Paying user area
Try for free
McKesson Corp. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Net Profit Margin since 2005
- Debt to Equity since 2005
- Price to Sales (P/S) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to McKesson Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Liquidity Ratios (Summary)
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Current ratio | |||||||
Quick ratio | |||||||
Cash ratio |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
- Current Ratio
- The current ratio exhibited a slight decline from 1.19 in 2011 to 1.08 in 2013, indicating a modest reduction in short-term liquidity during this period. Subsequently, it stabilized around 1.09 to 1.10 from 2014 to 2016, suggesting a steady capacity to cover current liabilities with current assets in the later years.
- Quick Ratio
- The quick ratio followed a downward trend from 0.68 in 2011 to 0.58 in 2013, reflecting a decrease in the company's ability to meet short-term obligations without relying on inventory. From 2014 onward, the ratio improved slightly and remained relatively stable between 0.62 and 0.63, indicating a modest recovery and consistent liquidity position excluding inventory.
- Cash Ratio
- The cash ratio showed a notable decline from 0.19 in 2011 to a low of 0.11 in 2013, signaling reduced immediate liquidity in terms of cash and cash equivalents. Although there was a slight increase to a peak of 0.16 in 2015, the ratio decreased again to 0.12 in 2016, suggesting fluctuating but generally lower availability of cash relative to current liabilities over the observed period.
Current Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Current assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Current ratio1 | |||||||
Benchmarks | |||||||
Current Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Elevance Health Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Current Assets
- Current assets demonstrated a generally increasing trend over the six-year period. Starting at $22,357 million in 2011, current assets increased marginally in the subsequent two years before experiencing a significant rise from 2013 to 2014. This upward momentum continued through 2015 and 2016, reaching $38,437 million by the end of the period, indicating a strengthening ability to cover short-term obligations and possible expansion of liquidity or working capital.
- Current Liabilities
- Current liabilities also exhibited a steady increase during the same timeframe. Beginning at $18,726 million in 2011, liabilities rose gradually each year, with a more pronounced jump from 2013 onward. By 2016, current liabilities reached $35,071 million. This parallel increase with current assets suggests rising operational or financial obligations, possibly related to growth or increased short-term financing.
- Current Ratio
- The current ratio remained relatively stable throughout the period, fluctuating slightly around 1.1. Starting at 1.19 in 2011, it decreased to 1.08 by 2013, then stabilized and maintained a value close to 1.1 for the remaining years. This stability indicates that, despite the increase in both assets and liabilities, the company's short-term liquidity position remained consistent, maintaining a balance between available current assets and current liabilities.
Quick Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Cash and cash equivalents | |||||||
Receivables, net | |||||||
Total quick assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Quick ratio1 | |||||||
Benchmarks | |||||||
Quick Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Elevance Health Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Total Quick Assets
- The total quick assets show a fluctuating upward trend over the six-year period. Starting at 12,799 million US dollars in 2011, the value slightly increased to 13,126 million in 2012 but declined to 12,431 million in 2013. From 2014 onwards, there was a marked increase, reaching 18,386 million in 2014, 21,255 million in 2015, and peaking at 22,028 million in 2016. This indicates an overall growth in liquid assets available to cover current liabilities, particularly in the latter three years.
- Current Liabilities
- Current liabilities consistently rose over the entire period, beginning at 18,726 million in 2011 and increasing steadily each year to reach 35,071 million in 2016. This represents a near doubling of short-term obligations, with notable jumps in 2014 and onward, suggesting an increasing reliance on current liabilities to finance operations or other activities.
- Quick Ratio
- The quick ratio remained below 1.0 throughout the period, indicating that quick assets were insufficient to cover current liabilities at face value. It started at 0.68 in 2011, then declined to 0.61 in 2012 and 0.58 in 2013, signaling a deterioration in liquidity during the early years. However, from 2014, the ratio slightly improved and stabilized around 0.62-0.63, despite the rising liabilities, reflecting the increase in quick assets helping to maintain a relatively steady liquidity position.
- Overall Analysis
- Despite the increasing total quick assets, the much larger and more rapid rise in current liabilities has led to consistently low liquidity ratios below 1. The firm’s quick ratio improvement starting in 2014 indicates some mitigation of liquidity risk through asset growth, but the level remains modest, suggesting potential vulnerability to short-term financial pressures if liabilities continue to grow at this pace. Monitoring the balance between quick assets and current liabilities will be critical going forward.
Cash Ratio
Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||||
Cash and cash equivalents | |||||||
Total cash assets | |||||||
Current liabilities | |||||||
Liquidity Ratio | |||||||
Cash ratio1 | |||||||
Benchmarks | |||||||
Cash Ratio, Competitors2 | |||||||
Abbott Laboratories | |||||||
Elevance Health Inc. | |||||||
Intuitive Surgical Inc. | |||||||
Medtronic PLC | |||||||
UnitedHealth Group Inc. |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= ÷ =
2 Click competitor name to see calculations.
- Total Cash Assets
- The total cash assets showed a fluctuating trend over the six-year period. Starting at $3,612 million in 2011, there was a decrease each year until 2013 where cash assets reached their lowest point at $2,456 million. Subsequently, a significant increase was observed in 2014 and 2015, peaking at $5,341 million. However, in 2016, the cash assets declined again to $4,048 million, indicating volatility in cash holdings.
- Current Liabilities
- Current liabilities displayed a consistent upward trend throughout the period. From $18,726 million in 2011, liabilities increased each year, reaching $35,071 million in 2016. The rate of increase was particularly notable from 2013 onwards, suggesting growing short-term obligations or operational scale expansion.
- Cash Ratio
- The cash ratio, representing the ability to cover current liabilities with cash assets, generally declined over the years. It began at 0.19 in 2011 and decreased to a low of 0.11 in 2013. Despite a slight recovery in 2014 and 2015, reaching 0.16, the ratio declined again in 2016 to 0.12. This trend indicates decreasing liquidity relative to current liabilities despite variations in cash assets.
- Overall Analysis
- While total cash assets experienced volatility with a peak in 2015, current liabilities consistently increased, resulting in a generally declining cash ratio. This suggests that although the company occasionally increased its cash reserves, these increases were insufficient to keep pace with the growth in current liabilities, potentially indicating tighter liquidity positions over the period analyzed.